Literature DB >> 18771906

2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease.

Yosefa Avraham1, Iddo Magen, Olga Zolotarev, Lia Vorobiav, Avital Nachmias, Orit Pappo, Yaron Ilan, Elliot M Berry, Zvi Ackerman.   

Abstract

BACKGROUND/AIM: Changes in tissue levels of 2-arachidonoylglycerol (2-AG), an endocannabinoid, during the evolution of bile duct ligation (BDL) may indicate that endocannabinoids have a role in the hemodynamic changes that occur in this condition.
METHODS: 2-AG levels, in various organs and vascular beds of BDL rats, 2 and 4 weeks post surgery, were determined. Untouched and sham-operated (SO) rats were used as controls.
RESULTS: 2-AG content of a specific organ was not a static finding and depended on the rat's age, the time from the surgical procedure and the type of procedure. The most pronounced changes were observed in BDL rats 4 weeks post surgery. In these rats, hepatic, pulmonary, cardiac and renal medullary and papillary 2-AG levels were highest observed. No changes in splenic, aortic and renal cortical 2-AG levels were observed. In addition a stepwise increase in 2-AG levels from the cortex to the papilla was detected and was followed by a decrease in creatinine clearance.
CONCLUSIONS: 2-AG probably has a role in the pathophysiologic changes in the liver, heart, lung and kidney that follows BDL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771906     DOI: 10.1016/j.plefa.2008.07.003

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  5 in total

1.  Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.

Authors:  Y Avraham; Nc Grigoriadis; T Poutahidis; L Vorobiev; I Magen; Y Ilan; R Mechoulam; Em Berry
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

2.  Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice.

Authors:  Y Avraham; N C Grigoriadis; I Magen; T Poutahidis; L Vorobiav; O Zolotarev; Y Ilan; R Mechoulam; E M Berry
Journal:  Br J Pharmacol       Date:  2009-09-18       Impact factor: 8.739

Review 3.  Cannabinoids, endocannabinoids, and related analogs in inflammation.

Authors:  Sumner H Burstein; Robert B Zurier
Journal:  AAPS J       Date:  2009-02-06       Impact factor: 4.009

Review 4.  Endocannabinoids: A Promising Impact for Traumatic Brain Injury.

Authors:  Lesley D Schurman; Aron H Lichtman
Journal:  Front Pharmacol       Date:  2017-02-17       Impact factor: 5.810

5.  Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.

Authors:  Olga Sadowska; Marta Baranowska-Kuczko; Anna Gromotowicz-Popławska; Michał Biernacki; Aleksandra Kicman; Barbara Malinowska; Irena Kasacka; Anna Krzyżewska; Hanna Kozłowska
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.